Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma
about
Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma
description
scientific article published on 21 February 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 2019
@uk
name
Anti-CD19 CAR T cells with hig ...... or refractory multiple myeloma
@en
Anti-CD19 CAR T cells with hig ...... or refractory multiple myeloma
@nl
type
label
Anti-CD19 CAR T cells with hig ...... or refractory multiple myeloma
@en
Anti-CD19 CAR T cells with hig ...... or refractory multiple myeloma
@nl
prefLabel
Anti-CD19 CAR T cells with hig ...... or refractory multiple myeloma
@en
Anti-CD19 CAR T cells with hig ...... or refractory multiple myeloma
@nl
P2093
P1433
P1476
Anti-CD19 CAR T cells with hig ...... or refractory multiple myeloma
@en
P2093
Alfred L Garfall
Anne Lamontagne
Brendan M Weiss
Bruce L Levine
Carl H June
Dan T Vogl
Donald L Siegel
Edward A Stadtmauer
Emily C Ayers
Irina Kulikovskaya
P356
10.1172/JCI.INSIGHT.127684
P50
P577
2019-02-21T00:00:00Z